Yhn BusinessStartups first seen 2 d ago, last 44 min ago, peak #4
PopVax's open-source Covid-19 vaccine enters Phase 1 trial
Original: PVX-001: open-source Covid-19 vaccine starts Phase 1 trial
Indian biotech PopVax has begun the first Phase 1 clinical trial of PVX-001, a Covid-19 vaccine it is developing as an open-source project, publishing details of the milestone on its company blog. The candidate is notable for being freely shared rather than patented, making it one of the first open-source vaccine efforts to reach human testing.
Why now: An open-source vaccine reaching clinical trials is a rare and significant milestone for accessible drug development.
Rank over time, top of the chart is #1. 105 snapshots from 2 d ago to 44 min ago.
Evidence
- PVX-001: open-source Covid-19 vaccine starts Phase 1 trial · jajoosam · 140
API: https://socialmediatrends-api.osmike.com/v1/trends/1751596